Skip to main content

Asuragen QuantideX qPCR BCR-ABL IS Kit

Asuragen has launched its QuantideX qPCR BCR-ABL IS kit, the first FDA cleared molecular diagnostic test for monitoring BCR-ABL1 transcripts in myeloid leukemia. The kit uses armored DNA technology to create World Health Organization Primary standard-aligned RNA-based calibrators. The assay reports patient results directly on the International Scale in accordance with the European LeukemiaNET and the National Comprehensive Cancer Network, the company said.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.